14 Mobile genetic elements (MGEs), such as plasmids, promote bacterial evolution 15 through horizontal gene transfer (HGT). However, the rules governing the repertoire 16 of traits encoded on MGEs remain unclear. In this study, we uncovered the central 17 role of genetic dominance shaping genetic cargo in MGEs, using antibiotic resistance 18 as a model system. MGEs are typically present in more than one copy per host 19 bacterium and, as a consequence, genetic dominance favors the fixation of dominant 20 mutations over recessive ones. Moreover, genetic dominance also determines the 21 phenotypic effects of horizontally acquired MGE-encoded genes, silencing recessive 22 alleles if the recipient bacterium already carries a wild-type copy of the gene. The 23 combination of these two effects governs the catalogue of genes encoded on MGEs, 24 dictating bacterial evolution through HGT.
Introduction
HGT between bacteria is largely mediated by specialized MGEs, such as plasmids 27 and bacteriophages, which provide an important source of genetic diversity and play 28 a fundamental role in bacterial ecology and evolution (1). The repertoire of accessory 29 genes encoded on MGEs and their ability to be phenotypically expressed in different 30 genetic backgrounds are key aspects of MGE-mediated evolution. There are several 31 factors known to impact horizontal gene transferability in bacteria, such as the level 32 of gene expression, the degree of protein connectivity, or the biochemical properties 33 of proteins (2-5), but the specific parameters that shape the repertoire of genes 34 encoded on MGEs remain largely unknown (6, 7). 35 Genetic dominance is the relationship between alleles of the same gene in which one 36 allele (dominant) masks the phenotypic contribution of a second allele (recessive). In 37 diploid or polyploid organisms, dominant alleles stem the establishment of new traits 38 encoded by recessive mutations (an effect known as Haldane's sieve (8, 9) ). Most 39 bacteria of human interest carry a single copy of their chromosome. In haploid 40 organisms like these, new alleles are able to produce a phenotype regardless of the 41 degree of genetic dominance of the underlying mutations. Therefore, the role of 42 genetic dominance in bacterial evolution has generally been overlooked. However, 43 the bacterial genome consists of more than the single chromosome; a myriad of 44 mobile genetic elements populate bacterial cells. Many MGEs, including plasmids 45 and filamentous phages, replicate independently of the bacterial chromosome and 46 are generally present at more than one copy per cell, with copy number ranging from 47 a handful to several hundred (10, 11). Extra-chromosomal MGEs thus produce an 48 island of local polyploidy in the bacterial genome (12, 13) . Moreover, HGT in bacteria 49 mostly occurs between close relatives (14, 15) , and genes encoded on mobile 50 elements can therefore create allelic redundancy with chromosomal genes. In light of 51 these evidences, genetic dominance should strongly affect both the emergence of 52 new mutations in MGE-encoded genes and the phenotypic effects of horizontally 53 transferred alleles. 54 55 To test whether genetic dominance determines the emergence of mutations in MGE- 56 encoded genes, we used a two-gene synthetic system that can confer tetracycline 57 resistance through dominant and recessive mutations (Figure 1 ). This construct 58 consists of a cI gene, encoding the bacteriophage λ CI repressor, in control of the 59 expression of a contiguous tetA gene, which encodes a tetracycline efflux pump (16). 60 This system provides tetracycline resistance when tetA transcription is derepressed. 61 Derepression can be achieved through mutations that either inactivate the cI gene or 62 disrupt the CI binding site upstream of tetA ( Figure 1A ). The repressor gene provides 63 a large target (714 bp), but we hypothesized that mutations inactivating cI would be 64 recessive, since in-trans copies of wild type CI would repress tetA. In contrast, the CI 65 binding site is a short target (166 bp), but mutations in this region are likely to be 66 dominant because they will lead to non-repressible, constitutive TetA production. 67 We produced two otherwise isogenic Escherichia coli MG1655 clones carrying the cI- 68 tetA system either as a single chromosomal copy (mono-copy treatment) or also 69 present on a pBAD plasmid with approximately 20 copies per cell (pCT, multi-copy 70 treatment) ( Figure 1A ). Fluctuation assays with both clones revealed a 4.84-fold 71 lower phenotypic tetracycline mutation rate in the multi-copy treatment clone, despite 72 the higher cI-tetA copy number (Likelihood ratio test statistic 55.0, P< 10 −12 , Figure   73 1B). To determine if this effect was due to differential access to dominant or 74 recessive mutations, we first analyzed the mutations in the cI-tetA system and 75 confirmed that they were located in different regions in each treatment (Wilcoxon 76 signed-rank test, W= 313, P≈ 10 -06 , Figure 1C , Table S1 ). Next, we generated 77 homozygous and heterozygous mutant clones in order to measure the coefficient of 78 dominance (h) of a subset of mutations [h ranges from 0 (completely recessive) to 1 79 (completely dominant), Figure S1-S2, Table S2 ]. As predicted, h was low or 80 intermediate in tetracycline resistance mutations recovered from the mono-copy 81 treatment and high in mutations from the multi-copy treatment (ANOVA effect of 82 treatment; F=70.02, df=1, P≈3x10 -5 ; Figure 1D ). Rifampicin mutation rates were determined to test the equal underlying mutation rate 89 of clones. Error bars represent 84% confidence intervals. (C) Location and type of 90 tetracycline resistance mutations in the mono-copy and multi-copy treatments are 91 indicated. In the cI-tetA system diagram, blue shading denotes the cI coding region, 92 and purple shading denotes the CI binding site plus the cI-tetA intergenic region. (D) 93 Coefficient of dominance (h) of 10 mutations described in panel C. Bars represent 94 the median of 8 biological replicates, error bars represent the interquartile range. 95 Our results indicate that interplay between genetic dominance and gene copy 96 number determines the rate at which phenotypic mutants emerge in bacteria. The 97 increased gene dosage provided by MGEs improves the chances of a beneficial 98 mutation being acquired but simultaneously masks the phenotypic contribution of the 99 newly acquired allele if it is recessive. To study the general effect of this interplay on 100 the evolution of MGE-encoded genes, we developed a computational model based 101 on the classic fluctuation assay ((17), Figure 2A and S3-S4). This model allows us to 102 simulate the acquisition and segregation of mutations located in an extra-103 chromosomal MGE, in this case a plasmid, with a given copy number. With this 104 information, we can explore the frequency of phenotypic mutants in the bacterial 105 population at any time point; this frequency will depend on the distribution of mutated 106 and wild-type alleles in each individual cell and on the coefficient of dominance of 107 those mutations ( Figure S4 ). The simulations showed that the frequency of 108 phenotypic mutants increases with plasmid copy number for mutations of high 109 dominance but decreases for mutations of low dominance (Figure 2A ). The results of the simulation prompted us to test our hypothesis in a more realistic 125 and meaningful experimental system. To study the effect of genetic dominance and 126 gene copy number on the emergence of phenotypic mutants, we used bacterial 127 housekeeping essential genes known to confer antibiotic resistance through 128 mutations. The genes studied were gyrA (DNA gyrase subunit A), rpsL (30S 129 ribosomal protein S12), and folA (dihydrofolate reductase). Mutations in these genes, 130 which are present as single copies in the chromosome, confer resistance to 131 quinolone, aminoglycoside and trimethoprim antibiotics, respectively (18, 19) . For 132 each gene, we produced two otherwise isogenic E. coli MG1655 clones with either 133 one copy of the gene (chromosomal) or multiple copies (chromosomal + plasmid, 134 Figure S5 ). We then calculated phenotypic mutation rates for each clone using 135 fluctuation assays with the appropriate antibiotics and sequenced the target genes in 136 the resistant clones to confirm the presence of mutations ( Figure 2B , Table S1 ). The 137 frequency of gyrA and rpsL mutants in the multi-copy treatment was lower than in the 138 mono-copy treatment (Likelihood ratio test statistic 49.48, P< 10 −12
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), suggesting that 139 antibiotic resistance mutations in these genes are recessive, in line with previous 140 works in the field (20, 21). Conversely, the mutation rate for folA in the multi-copy 141 treatment increased 3-fold (Likelihood ratio test statistic 5.38, P= 0.04), suggesting 142 that this gene confers trimethoprim resistance through dominant mutations. To test 143 this possibility, we determined the coefficient of dominance of a common mutation in 144 each gene, confirming that mutations in GyrA D87N (h=0.043) and RpsL K43T (h=0) were 145 recessive, whereas mutation in FolA L28R (h=0.748) was dominant ( Figure 2C , S1 and 146 S6, for more details on the mechanistic basis of genetic dominance of resistance 147 mutations see supplementary text). 148 While these results show that genetic dominance shapes the emergence of 
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Strains, plasmids and media 234 All the strains and plasmids used in this study are detailed in Table S3 . Experiments 235 were performed using BBL Muller Hinton II agar or cation adjusted broth (Becton 236 Dickinson) unless specified. Antibiotics were supplied by Sigma-Aldrich and were 237 used at the following concentrations: carbenicillin 100 µg/ml, chloramphenicol 30 238 µg/ml, nalidixic acid 30 µg/ml, streptomycin 100 µg/ml, rifampicin 100 µg/ml, 239 trimethoprim 2 µg/ml and 16 µg/ml, and tetracycline 15 µg/ml. Cultures were routinely 240 grown at 37ºC with shaking (225 rpm). Plasmids were extracted using a commercial 241 miniprep kit (Macherey-Nagel) and were transformed into TSS competent cells (31). 242 Cloning and site directed mutagenesis 243 The gyrA, rpsL and folA wild-type alleles were PCR amplified using HS Taq Mix 244 (PCR biosystems) polymerase, using the primers listed in table S4 and MG1655   245 chromosomal DNA as template. The cI-tetA system was amplified similarly, but using 246 IBDS1 as a template (16). Purified PCRs were subsequently cloned into the pBAD 247 TOPO TA Expression kit (Thermo-Fisher) following manufacturer instructions. We 248 selected clones in which the insert was cloned in the opposite direction from that of 249 the P BAD promoter to ensure that expression is driven only from the cognate 250 promoter. Correct clones were identified by PCR and Sanger sequenced to give rise 251 to pBAD-gene and pCT plasmids (Table S3 ). 252 Site-directed mutagenesis was performed on the pBAD plasmids carrying wild-type 253 alleles to construct the gyrA D87N , rpsL K43T Table S4 for primers) mutated and 258 wild-type alleles into the pBGC backbone ( Figure S5 and Table S3 ) 259 Tetracycline resistant mutations in the pCT plasmid isolated in the fluctuation assays 260 were purified by plasmid extraction and re-transformed into MG1655, selecting in 261 carbenicillin and tetracycline plates to isolate pCT mutated plasmids from the wild-262 type version, that could be coexisting under heteroplasmy. Isolated pCT plasmids 263 and chromosomal mutants carrying cI-tetA mutated cassette were PCR amplified 264 (Phusion Hot Start II DNA Polymerase; Thermo-Fisher) and simultaneously Gibson 265 assembled (NEBuilder HiFi DNA Assembly kit; New England Biolabs) into the pBAD 266 and pBGC backbones using the primers listed in Table S4 to give rise to pBAD and 267 pBDSM plasmids carrying mutated alleles of the cI-tetA system ( Figure S1 and Table   268   S3 ). 269 Fluctuation assays for mutation rate determination functions of the Rsalvador package for R (32). We plotted 84% confidence intervals 282 because it has been demonstrated that they better convey statistical significance 283 than 95% confidence intervals when dealing with mutation rate data (33). 284 Mono-copy and multi-copy strains of gyrA and rpsL presented the same antibiotic 285 resistance levels, indicating that target overexpression did not increase the level of 286 resistance for these genes (Table S2 ). However, and as previously reported (34), 287 folA overexpression led to a 8-fold increase in the trimethoprim resistance level in the 288 multi-copy treatment. To perform the mutation rate assay, we used 4 times the IC 90 of 289 trimethoprim for each clone (2 and 16 µg/ml for the mono-copy and multi-copy 290 treatment, respectively). Sequencing of folA PCR products revealed mutations in all 291 the colonies tested from the mono-copy treatment, but only for approximately 10% of 292 the ones from the multi-copy treatment. This result could be due to the lack of fixation 293 of folA mutations, which can be maintained at a low frequency in heteroplasmy and 294 not be evident in the chromatogram, or due to the access to different resistance 295 mutations in this treatment. To solve this problem and recover only folA mutants, we 296 introduced an extra step in the fluctuation assays for the multi-copy treatment, where 297 we restreaked the colonies from 16 to 50 µg/ml trimethoprim plates. This step 298 allowed us to recover colonies carrying folA mutations only (avoiding false positives) 299 while at the same time allowing the recovery of colonies carrying folA mutations even 300 if the frequency of folA mutated alleles in heteroplasmy would have been too low to 301 initially grow on this concentration during a fluctuation assay (avoiding false 302 negatives) (Table S1 ). 303 For rpsL, we were not able to recover a single resistant colony in the fluctuation 304 assays for the multi-copy treatment (Table S1 ). Subsequent analyses revealed that 305 the coefficient of dominance of the most common rpsL mutation isolated in the 306 chromosome is 0. The complete recesiveness of rpsL streptomycin resistance 307 mutations explains the absence of resistant mutants in the multi-copy treatment 308 because, even if the plasmid-mediated copy of rpsL mutates and reaches fixation 309 prior to plating, the wild type chromosomal copy of the gene masks the resistance 310 phenotype. Therefore, for phenotypic resistant mutants to appear, both chromosomal 311 and plasmid copies of the gene should mutate (and reach fixation in the cell), which 312 is extremely unlikely. In Figure 2B we present the fold change of streptomycin 313 resistance phenotypic mutation rate using the mutation rate calculated for the mono-314 copy treatment and the limit of detection of the mutation rate for the multi-copy 315 treatment. 316 Rifampicin mutation rates were performed to confirm that the underlying mutation 317 rate is equal for all clones used in this study (Figure 1 and S11) . where IC 90AA , IC 90aA and IC 90aa are the IC 90 of the homozygous wild-type, 333 heterozygous and homozygous mutant clones, respectively. Since there are two 334 different heterozygous clones ( Figure S1 ), we calculated h as the median value of 335 four independent replicates of each heterozygous clone (n= 8, see Table S2 ). 336 IC 90 values were obtained following (37), with some alterations. In short, strains were 337 streaked from freeze stock onto Mueller Hinton II agar plates and incubated over Conjugation assays 351 We developed an experimental model system to determine the frequencies of 352 conjugation of plasmids pSEVA121-gyrA, pSEVA121-gyrA D87N , pSEVA121-folA and 353 pSEVA121-folA L28R between E. coli strains ( Figure S7 ). pSEVA121 is a vector 354 carrying the IncP-type RK2 (also called RP4) replicon, with a trfA replication initiator 355 protein gene plus the oriV origin of replication, and the oriT origin of transfer. 356 pSEVA121 displays therefore low copy-number in the host cell (ca. 4 copies/cell) 357 (38), representing a great model system to reproduce the features of a natural 358 conjugative plasmid. To mobilize pSEVA121 we used strain ß3914 as donor, which is 359 auxothropic for diaminopimelic acid and carries RP4 conjugation machinery inserted 360 in the chromosome. As a recipient we used E. coli MG1655 (Table S3 ). CARD prevalence data containing an analysis of 82 pathogens with more than 386 89,000 resistomes and more 175,000 antimicrobial resistance allele sequences was 387 obtained from the CARD website (23) (downloaded on 18/09/2019). 388 We downloaded all available bacterial integrative and conjugative elements (ICEs) 389 from ICEberg 2.0 database (39), amounting to a total of 806 ICEs from which 662 390 were conjugative type IV secretion system (T4SS)-type ICEs, 111 were 391 chromosome-borne integrative and mobilizable elements (IMEs), and 33 were cis-392 mobilizable elements (CIMEs). A total of 741 perfect and strict hits from 267 ICEs 393 were identified using CARD RGI (version 4.2.2, parameters used: DNA sequence, 394 perfect and strict hits only, exclude nudge, high quality/coverage, and we used 395 DIAMOND to align the CDS against the CARD database). 396 We downloaded all complete bacterial genomes from NCBI, a total of 13,169 397 genomes (Assembly level: complete, downloaded on 15/02/2019). We used the 398 algorithm phiSpy to identify prophages in the bacterial chromosomes and we 399 predicted a total of 30,445 prophages in 7,376 genomes (40). To study the presence 400 of genes conferring antibiotic resistance in prophages, we extracted the CDS 401 overlapping with prophages and we predicted their resistome using the command 402 line tool CARD RGI as above. 403 We then used the antibiotic resistance data from prophages, ICEs, plasmids, and 404 chromosomes to calculate the prevalence of the following Antibiotic Resistance Connectivity data for all protein families was downloaded from the STRING database 410 (41), and the number of high-confidence interactions (>700 STRING confidence) was 411 determined for each protein family. 412 Stochastic model 413 We assume that plasmids replicate randomly throughout the cell cycle until reaching 414 an upper limit determined by the plasmid copy number control 415 mechanism. Therefore, the probability of plasmid replication can be modelled as GitHub) ( Figure S3 ). 424 We also consider that plasmids segregate randomly during cell division. The 425 probability that each plasmid is inherited to one of the daughter cells is a random 426 process that follows a binomial distribution. By implementing an agent-based 427 extension of the replication-mutation model coupled with the segregation dynamics, 428 we simulated the intracellular plasmid dynamics of individual cells in an exponentially 429 growing population ( Figure S4 ). The frequency of phenotypic mutants observed in 430 the population at the end of the numerical experiment was estimated from the 431 fraction of mutated/wild-type alleles in each individual cell and the coefficient of 432 dominance of those mutations (ℎ). The results presented in this study were obtained 433 after 10 ! simulation runs in a range of plasmid copy numbers (Figure 2A ). Finally, we 434 used Rsalvador package to estimate from this synthetic data the -fold change in 435 phenotypic mutation rate with respect to chromosomally-encoded genes. Replication events increase the number of copies of plasmids carried in a cell until 662 the cell divides and plasmids are segregated randomly between both daughter cells. 663 In this example, we consider that a mutation occurred in a copy of a WT plasmid at We consider that mutations can occur at any point during plasmid replication, so we track the fraction of mutant alleles in each cell (WT alleles represented in grey, with the fraction of mutant plasmids in each cell is represented with a gradient of red). At the end of the computational experiment (in the case illustrated here 5 generations, but in the simulations discussed in the manuscript 25 generations), we simulate a fluctuation assay in order to estimate the phenotypic mutant frequency from the fraction of mutated/wild-type alleles in each individual and the degree of dominance of the mutation. Red circles represent cells that survived the fluctuation assay and grey cells those that did not. Note how the mutant frequency decreases with the degree of dominance of the mutation (bars). Ontology group "mechanism of antibiotic resistance" in plasmids and chromosomes. 747 We tried to explore the potential effect of genetic dominance on the general 748 distribution of all resistance genes on plasmid/chromosomes according to their 749 Antibiotic Resistance Ontology (ARO, grouped by "mechanism of antibiotic 750 resistance", data obtained from CARD). These groups include genes that are not 751 necessary present on the chromosomes of recipient bacteria; therefore genetic 752 dominance relationships between alleles may not impact their transferability. Actually, 753 we hypothesized that those horizontally transferred genes with no pre-existing alleles 754 on the recipient cells would be frequent in MGEs, since their phenotypic effect would 755 not be masked regardless of the dominance of the allele. In line with this idea, we 756 observed that the "antibiotic inactivation" category, which is mainly comprised of Rifampicin resistance phenotypic mutation rates were performed to confirm the 766 normo-mutator status of the clones used in this study. There were no significant 767 differences in rifampicin mutation rates among strains (Likelihood Ratio Test P>0.13 768 in all cases).
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